Skip to main content

Table 4 Risk of human papillomavirus-related cancer among patients with end-stage renal disease by type of renal replacement therapy

From: Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis - an observational cohort study

 

Dialysis

Graft function

  
 

No.

IR (95% CI)a

No

IR (95%CI)a

IRR (95% CI)

P value

Head and neckb

8

21.4 (10.7-42.7)

10

42.9 (23.1-79.6)

2.00 (0.71-5.85)

0.1

Vulva and vagina

5

35.0 (14.5-84.0)

10

116 (62.3-215)

3.31 (1.13-9.69)

0.03

Cervix

8

55.9 (28.0-112)

4

46.3 (17.4-123)

0.83 (0.25-2.75)

0.8

Anal

5

13.3 (5.55-32.1)

7

30.0 (14.3-62.9)

2.25 (0.71-7.08)

0.2

Penis

3

13.0 (4.18-40.2)

2

13.6 (3.40-54.4)

1.05 (0.18-6.29)

0.9

All HPV-related

29

77.4 (53.8-111)

33

141 (100–198)

1.83 (1.08-3.12)

0.02

  1. Abbreviations: No. number cancers, CI confidence interval, IR incidence rate, IRR unadjusted incidence rate ratio, IR incidence rate.
  2. a Per 100,000 person-years.
  3. b HPV-related head and neck cancer subsites as outlined in Table 1.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us